# The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

> **NCT01767909** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Southern California** · enrollment: 240 (actual)

## Conditions studied

- Amnestic Mild Cognitive Impairment
- Alzheimer's Disease

## Interventions

- **DRUG:** Insulin (Humulin® R U-100)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01767909
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-08
- **Primary completion:** 2018-12-11
- **Final completion:** 2018-12-11
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01767909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01767909, "The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01767909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*